103 related articles for article (PubMed ID: 8816581)
21. Workshop findings on the ovine homologue of CD5.
Keech CL; Brandon MR
Vet Immunol Immunopathol; 1991 Jan; 27(1-3):103-7. PubMed ID: 1708543
[No Abstract] [Full Text] [Related]
22. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.
Tateyama H; Eimoto T; Tada T; Hattori H; Murase T; Takino H
Am J Clin Pathol; 1999 Feb; 111(2):235-40. PubMed ID: 9930146
[TBL] [Abstract][Full Text] [Related]
23. Aberrant immunophenotypes of mantle cell lymphomas.
Wohlschlaeger Ch; Lange K; Merz H; Feller AC
Leuk Lymphoma; 2003 Feb; 44(2):269-73. PubMed ID: 12688344
[TBL] [Abstract][Full Text] [Related]
24. CD5+ true SLL/CLL with plasmacytic differentiation and an unusual 1p36 translocation: case report and review of the literature.
Evans HL; Polski JM; Deshpande V; Dunphy CH
Leuk Lymphoma; 2000 Nov; 39(5-6):625-32. PubMed ID: 11342346
[TBL] [Abstract][Full Text] [Related]
25. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology.
Leers MP; Theunissen PH; Ramaekers FC; Schutte B; Nap M
Hum Pathol; 2000 Apr; 31(4):422-7. PubMed ID: 10821487
[TBL] [Abstract][Full Text] [Related]
26. [Clinical usefulness of the immunophenotypic study of circulating lymphocytes in leukemic lymphoproliferative diseases].
Büchi G; Messina M; Girotto M; Termine G; Morello M; Orlassino R; Autino R; Grosso E
Pathologica; 1995 Feb; 87(1):50-5. PubMed ID: 7567166
[TBL] [Abstract][Full Text] [Related]
27. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
[TBL] [Abstract][Full Text] [Related]
28. [At the crossroads between B lymphoproliferative syndromes to autoimmune diseases are CD5-positive B-lymphocytes: a new hypothesis].
Youinou P
Bull Acad Natl Med; 1999; 183(1):159-69; discussion 170. PubMed ID: 10371774
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
Porwit A
Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
[TBL] [Abstract][Full Text] [Related]
30. PCR analysis of immunoglobulin heavy chain and TCR gene rearrangements in diagnosis of lymphoproliferative disorders on formalin-fixed, paraffin-embedded tissues.
Svachova M; Tichy M
Neoplasma; 2008; 55(1):36-41. PubMed ID: 18190238
[TBL] [Abstract][Full Text] [Related]
31. CD5+ B cells and uveitis.
Jiménez-Alonso J; Omar M; López-Nevot MA; Pérez-Alvarez F; Toribio M; Hidalgo C; Sabio JM
Ann Rheum Dis; 2002 Sep; 61(9):854-5. PubMed ID: 12176820
[No Abstract] [Full Text] [Related]
32. CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour.
Wenzel C; Dieckmann K; Fiebiger W; Mannhalter C; Chott A; Raderer M
Leuk Lymphoma; 2001 Aug; 42(4):823-9. PubMed ID: 11697516
[TBL] [Abstract][Full Text] [Related]
33. [The immunophenotypic lymphocyte analysis of orbital lymphadenosis and its significance].
Yu YH; Li J; Zhang PW
Zhonghua Yan Ke Za Zhi; 1994 May; 30(3):210-3. PubMed ID: 7843004
[TBL] [Abstract][Full Text] [Related]
34. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse.
Ferry JA; Yang WI; Zukerberg LR; Wotherspoon AC; Arnold A; Harris NL
Am J Clin Pathol; 1996 Jan; 105(1):31-7. PubMed ID: 8561085
[TBL] [Abstract][Full Text] [Related]
35. CD30+ lymphoproliferative disorders of the skin: still an open question.
Alaibac M; Zarian H; Russo I; Peserico A
G Ital Dermatol Venereol; 2012 Dec; 147(6):545-52. PubMed ID: 23149700
[TBL] [Abstract][Full Text] [Related]
36. Normal CD5+ B lymphocytes are poor stimulators in the autologous mixed lymphocyte reaction (AMLR).
Fernandez LA; Cheng R; Sadek I; Nevill TJ; Macsween JM
Clin Exp Immunol; 1997 Jun; 108(3):557-61. PubMed ID: 9182907
[TBL] [Abstract][Full Text] [Related]
37. Functional and morphological development of lymphoid tissues and immune regulatory and effector function in rhesus monkeys: cytokine-secreting cells, immunoglobulin-secreting cells, and CD5(+) B-1 cells appear early in fetal development.
Makori N; Tarantal AF; Lü FX; Rourke T; Marthas ML; McChesney MB; Hendrickx AG; Miller CJ
Clin Diagn Lab Immunol; 2003 Jan; 10(1):140-53. PubMed ID: 12522052
[TBL] [Abstract][Full Text] [Related]
38. Conjunctival CD5+ MALT lymphoma.
Heuring AH; Franke FE; Hütz WW
Br J Ophthalmol; 2001 Apr; 85(4):498-9. PubMed ID: 11302130
[No Abstract] [Full Text] [Related]
39. Blood group antibodies are made by CD5+ and by CD5- B cells.
Wuttke NJ; Macardle PJ; Zola H
Immunol Cell Biol; 1997 Oct; 75(5):478-83. PubMed ID: 9429896
[TBL] [Abstract][Full Text] [Related]
40. The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders.
Morice WG
Am J Clin Pathol; 2007 Jun; 127(6):881-6. PubMed ID: 17509985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
